107 related articles for article (PubMed ID: 12210808)
21. High expression of apoptosis-regulating proteins in Burkitt's lymphomas.
Pagnano KB; Silva MD; Vassallo J; Souza MS; Costa FF; Saad ST
Haematologica; 2002 Mar; 87(3):ELT16. PubMed ID: 11869962
[No Abstract] [Full Text] [Related]
22. Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma.
Martini M; D'Alò F; Pierconti F; Ricci R; Capelli A; Leone G; Larocca LM
Haematologica; 2000 Oct; 85(10):1019-23. PubMed ID: 11025591
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma.
Michels J; Foria V; Mead B; Jackson G; Mullee M; Johnson PW; Packham G
Br J Haematol; 2006 Mar; 132(6):743-6. PubMed ID: 16487175
[TBL] [Abstract][Full Text] [Related]
24. Developmental expression patterns of Bcl-2, Bcl-x, Bax, and Bak in teeth.
Krajewski S; Hugger A; Krajewska M; Reed JC; Mai JK
Cell Death Differ; 1998 May; 5(5):408-15. PubMed ID: 10200490
[TBL] [Abstract][Full Text] [Related]
25. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM
Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366
[TBL] [Abstract][Full Text] [Related]
26. Bak but not Bax is essential for Bcl-xS-induced apoptosis.
Lindenboim L; Kringel S; Braun T; Borner C; Stein R
Cell Death Differ; 2005 Jul; 12(7):713-23. PubMed ID: 15861188
[TBL] [Abstract][Full Text] [Related]
27. Expression of bcl-2, bcl-x, bax and bak in renal parenchyma, oncocytomas and renal cell carcinomas.
Pammer J; Exner M; Regele H; Haitel A; Weninger W; Horvat R; Susani M
Pathol Res Pract; 1998; 194(12):837-45. PubMed ID: 9894249
[TBL] [Abstract][Full Text] [Related]
28. Expression of Bcl-2 family proteins in psoriasis.
Batinac T; Zamolo G; Hadzisejdić I; Zauhar G; Brumini G; Ruzić A; Persić V
Croat Med J; 2007 Jun; 48(3):319-26. PubMed ID: 17589974
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of Bak expression in oral tongue squamous cell carcinomas.
Xie X; Clausen OP; Boysen M
Oncol Rep; 2003; 10(2):369-74. PubMed ID: 12579274
[TBL] [Abstract][Full Text] [Related]
30. [Expression and clinical significance of Mcl-1 in T-cell non-Hodgkin's lymphoma].
Lin XB; Jiang WQ; Zhong XY; Luo RZ
Ai Zheng; 2007 Apr; 26(4):435-9. PubMed ID: 17430669
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis-regulating proteins and prognosis in diffuse large B cell non-Hodgkin's lymphomas.
Pagnano KB; Silva MD; Vassallo J; Aranha FJ; Saad ST
Acta Haematol; 2002; 107(1):29-34. PubMed ID: 11818669
[TBL] [Abstract][Full Text] [Related]
32. A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma.
Piris MA; Mollejo M; Campo E; Menárguez J; Flores T; Isaacson PG
Histopathology; 1998 Sep; 33(3):230-9. PubMed ID: 9777389
[TBL] [Abstract][Full Text] [Related]
33. Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection.
Schlaifer D; Krajewski S; Galoin S; Rigal-Huguet F; Laurent G; Massip P; Pris J; Delsol G; Reed JC; Brousset P
Am J Pathol; 1996 Jul; 149(1):177-85. PubMed ID: 8686741
[TBL] [Abstract][Full Text] [Related]
34. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.
Kitada S; Andersen J; Akar S; Zapata JM; Takayama S; Krajewski S; Wang HG; Zhang X; Bullrich F; Croce CM; Rai K; Hines J; Reed JC
Blood; 1998 May; 91(9):3379-89. PubMed ID: 9558396
[TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis detects ubiquitous expression of apoptotic regulators in B cell non-Hodgkin's lymphomas.
Xerri L; Devilard E; Bouabdallah R; Hassoun J; Chaperot L; Birg F; Plumas J
Leukemia; 1999 Oct; 13(10):1548-53. PubMed ID: 10516756
[TBL] [Abstract][Full Text] [Related]
36. Expression of Bcl-2, Bcl-x, Mcl-1, Bax and Bak in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause.
Wu X; Blanck A; Olovsson M; Henriksen R; Lindblom B
J Steroid Biochem Mol Biol; 2002 Jan; 80(1):77-83. PubMed ID: 11867266
[TBL] [Abstract][Full Text] [Related]
37. High-grade malignant non-Hodgkin's lymphomas differ from low-grade lymphomas in the extent of apoptosis and their expression of bcl-2, mcl-1, bax and p53.
Soini Y; Raunio H; Pääkkö P
Tumour Biol; 1998; 19(3):176-85. PubMed ID: 9591044
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation.
Menendez P; Vargas A; Bueno C; Barrena S; Almeida J; De Santiago M; López A; Roa S; San Miguel JF; Orfao A
Leukemia; 2004 Mar; 18(3):491-8. PubMed ID: 14724650
[TBL] [Abstract][Full Text] [Related]
39. Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia.
Packham G; Stevenson FK
Immunology; 2005 Apr; 114(4):441-9. PubMed ID: 15804279
[TBL] [Abstract][Full Text] [Related]
40. Bcl-2 and bax protein expression in indolent versus aggressive B-cell non-Hodgkin's lymphomas.
Wheaton S; Netser J; Guinee D; Rahn M; Perkins S
Hum Pathol; 1998 Aug; 29(8):820-5. PubMed ID: 9712423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
